(19)
(11) EP 1 337 634 A2

(12)

(88) Date of publication A3:
13.03.2003

(43) Date of publication:
27.08.2003 Bulletin 2003/35

(21) Application number: 01998630.6

(22) Date of filing: 28.11.2001
(51) International Patent Classification (IPC)7C12N 15/11, C12N 15/12, C12N 15/62, C07K 14/705, C07K 16/28, A01K 67/027, G01N 33/577, G01N 33/68
(86) International application number:
PCT/US0144/859
(87) International publication number:
WO 0204/4364 (06.06.2002 Gazette 2002/23)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.11.2000 US 728420

(71) Applicants:
  • Amgen Inc.
    Thousand Oaks, CA 91320-1799 (US)
  • AMGEN CANADA INC.
    Missisauga,Ontario L5N 6J5 (CA)

(72) Inventors:
  • YOSHINAGA, Steven, Kiyoshi
    Thousand Oaks, CA 91360 (US)
  • MAK, Tak, Wah
    Toronto, Ontario M5R 1G5 (CA)
  • SHAHINIAN, Arda
    Markham, Ontario L3S 3P6 (CA)
  • BLADT, Anna, Tafuri
    Toronto, Ontario M5G 2K2 (CA)
  • SENALDI, Giorgio
    Thousand Oaks, CA 91362 (US)

(74) Representative: Brown, John David 
FORRESTER & BOEHMERTPettenkoferstrasse 20-22
80336 München
80336 München (DE)

   


(54) NOVEL POLYPEPTIDES INVOLVED IN IMMUNE RESPONSE